EUCTR2018-001387-39-DE进行中（未招募）1 期
A prospective, randomized, controlled trial to assess the effect of long-term oxygen therapy on 6-minute walking distance, clinical parameters and hemodynamics in patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) - SOPHA
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Patients in both groups (n = 40) with precapillary PH, WHO class I -IV (mPAP = 25 mm Hg, pulmonary arterial occlusion pressure =15 mm Hg), who are stable on optimized pharmacological treatment for at least six weeks and who do not suffer from other cardio-pulmonary disease will be recruited if arterial or capillary O2 partial pressure is repeatedly (<60 mmHg; alternatively, 90% of O2 saturation) at rest and during physical activity hypoxemia still persist (O2 partial pressure <60 mmHg SpO2 90 % ). - men and women 18 years of age or older - patient is diagnosed with Pulmonary Arterial Hypertension (World Health Organization (WHO) Category Group 1-3 (by the WHO Clinical classification system)), including Idiopathic (IPAH), Heritable PAH (HPAH, Familial PAH), and CTEPH, with exceptions as noted in exclusion criteria - patient (or patient's legally authorized representative) is willing and able to provide written informed consent - patient is willing and able to comply with the protocol, including required follow-up visits - Patient experiences oxygen desaturations below 90% (or pO2 below 60 mmHg) at rest with oxygen desaturations below 90% (or pO2 below 60 mmHg) during physical activity - patient has a stable functional class of PAH with no changes of medication during the last six weeks before inclusion
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •- Patient is a female who is pregnant, nursing, or of child bearing potential and is not on a reliable form of birth control - patient has already been treated with long-term oxygen therapy within the last 3 weeks. - patient with pulmonary venous hypertension - significant functional limitation in lung function tests (FEV1>60%,TLC <60%) and CT morphological signs of pulmonary disease - significant left heart disease, requires acute pharmacological or interventional treatment - unstable conditions requiring pharmacological or other treatment, intensive care or relevant severe concomitant disease - patient is enrolled, has participated within the last thirty days, or is planning to participate, in a concurrent drug and/or device study during the course of this clinical trial. Co-enrolment in concurrent trials is only allowed with documented pre-approval from the study manager that there is not a concern that co-enrolment could confound the results of this trial. - patient has been initiated on a new oral or parenteral PAH therapy in the last two months - patient has had a recent (within three months) or otherwise unresolved infection requiring antibiotic treatment - patient with a cardiac index (CI) <1.8L/min/m2 - patient is Functional Class IV (New York Heart Association (NYHA)) active smoking status - patient with severe resting desaturation (repeatedly SpO2 =85%) or severe exercise-induced desaturation (SpO2 <80% for =10 minutes)
研究者
相似试验
已完成
3 期
A prospective, randomized, controlled trial to compare the effectiveness of endoscopic sphincterotomy with endoscopic papillary large balloon dilation for removal of bile duct stonesbile duct stones, ductal stonesJPRN-UMIN000013887Kansai Endoscopic Device Selection (EDS) Working Group60
已完成
不适用
Study to compare the clinical outcomes of coiled-end versus straight-end Swan-Neck peritoneal dialysis (PD) cathetersEnd stage renal disease requiring renal replacement therapyUrological and Genital DiseasesEnd-stage renal diseaseISRCTN05846916Shanghai Ruijin Hospital, Shanghai Jiaotong University, School of Medicine (China)80
已完成
不适用
A prospective, randomised, controlled trial to evaluate the efficacy and safety of endoscopic choroid plexus coagulation with third ventriculostomy in the treatment of idiopathic Normal Pressure Hydrocephalusormal Pressure Hydrocephalus (NPH)Nervous System DiseasesNormal Pressure Hydrocephalus (NPH)ISRCTN29863839The Frenchay Hydrocephalus Research Fund (UK)
进行中（未招募）
1 期
prospective, randomized, controlled study evaluating the effect of conversion from tacrolimus treatment to mTor inhibitor-based immunosuppression + tacrolimus to boost conversion to positive SARS-CoV-2 serology after a fourth dose of the vaccine of SARS-CoV-2 mRNA in solid organ transplant recipients who have not previously responded.Seroconversion is evaluated after changing treatment from tacrolimus to tacrolimus + mTOR inhibitor in solid organ transplant patients who have not responded to the first three doses of the vaccineMedDRA version: 21.0Level: PTClassification code 10080575Term: Solid organ transplantSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2022-000617-13-ESFundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)50
已完成
不适用
A prospective randomized controlled trial to investigate the effect of early administration of antibiotics for patients with suspected sepsissepsisNL-OMON43665Vrije Universiteit Medisch Centrum2,800